| Literature DB >> 9302214 |
F Nicoletti1, G Mancuso, F A Ciliberti, C Beninati, M Carbone, S Franco, V Cusumano.
Abstract
The lethal effects occurring in neonatal (<24-h-old) BALB/c mice after challenge with 25 mg of lipopolysaccharide (LPS) per kg of body weight were significantly counteracted by pretreatment with recombinant interleukin-10 (rIL-10; 25 or 50 ng/mouse). Concordantly, blockage of endogenous IL-10 with the SXC1 monoclonal antibody increased LPS-induced mortality. Both IL-10 and SXC1 modulated the release of tumor necrosis factor alpha (TNF-alpha) so that, relative to controls, peak TNF-alpha values after LPS challenge were decreased by rIL-10 and increased by anti-IL-10.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9302214 PMCID: PMC170607 DOI: 10.1128/cdli.4.5.607-610.1997
Source DB: PubMed Journal: Clin Diagn Lab Immunol ISSN: 1071-412X